临床试验/NCT07275008

NCT07275008尚未招募不适用

Efficacy and Long-term Prognosis of Auxiliary Liver Transplantation

Zhi-Jun Zhu0 个研究点目标入组 100 人开始时间: 2025年12月1日最近更新: 2025年12月10日

试验速览

阶段: 不适用
状态: 尚未招募
发起方
入组人数: 100
主要终点: Overall survival

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

The objective of this observational study is to systematically compare the efficacy and patient prognosis between auxiliary liver transplantation and living donor liver transplantation, and to explore the postoperative recovery, survival rate, rejection, postoperative complications, and long-term prognosis of patients undergoing auxiliary liver transplantation.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

性别: All
接受健康志愿者: 否

入选标准

•Patients who underwent auxiliary liver transplantation or living donor liver transplantation (LDLT).
•Patients with complete medical records and follow-up data.

排除标准

•Patients who underwent retransplantation.
•Patients who underwent other organ transplantation (or multiorgan transplantation).
•Patients with severe missing postoperative follow-up data or loss to follow-up.

结局指标

主要结局

Overall survival

时间窗: Within one year after liver transplantation

次要结局

Complications(Within one year after liver transplantation)
changes in peripheral blood lymphocytes(within 3 months after liver transplantation)

研究者

发起方

Zhi-Jun Zhu

申办方类型

Other

责任方

Sponsor Investigator

主要研究者

Zhi-Jun Zhu

Professor

Beijing Friendship Hospital

相似试验

已完成

不适用

Clinical Performance of Two Different Resin-Matrix Ceramic Restorations

NCT07265609Mansoura University12

Enrolling By Invitation

不适用

"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDNHypertension

NCT07273877Shanghai Golden Leaf MedTec Co. Ltd1,000

招募中

3 期

Extension Study for Participants in Studies That Include Pembrolizumab

2022-501254-10-00Merck Sharp & Dohme LLC1,133

招募中

3 期

A study to evaluate the efficacy and safety of Clascoterone solution in treatment of male pattern hair loss.Androgenetic Alopecia

2023-504421-39-00Cassiopea S.p.A.629

尚未招募

2 期

Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT07266155Longbio Pharma30